These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19861407

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L, Xiang B, Muthuswamy SK.
    Cancer Res; 2006 May 15; 66(10):5201-8. PubMed ID: 16707444
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L, Focaccetti C, Cereda V, Lista F, Vitolo D, Trono P, Gallo P, Amici A, Monaci P, Mattei M, Modesti M, Forni G, Kraus MH, Muraro R, Modesti A, Bei R.
    Int J Oncol; 2007 Feb 15; 30(2):381-92. PubMed ID: 17203220
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
    Kunz C, Borghouts C, Buerger C, Groner B.
    Mol Cancer Res; 2006 Dec 15; 4(12):983-98. PubMed ID: 17189388
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W, Rosenberg MP, DiGiovanni J.
    Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987
    [Abstract] [Full Text] [Related]

  • 32. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
    Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG.
    Cell; 2006 Aug 11; 126(3):489-502. PubMed ID: 16901783
    [Abstract] [Full Text] [Related]

  • 33. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
    Aurisicchio L, Marra E, Luberto L, Carlomosti F, De Vitis C, Noto A, Gunes Z, Roscilli G, Mesiti G, Mancini R, Alimandi M, Ciliberto G.
    J Cell Physiol; 2012 Oct 20; 227(10):3381-8. PubMed ID: 22213458
    [Abstract] [Full Text] [Related]

  • 38. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer.
    Han JS, Crowe DL.
    Anticancer Res; 2010 Sep 20; 30(9):3407-12. PubMed ID: 20944115
    [Abstract] [Full Text] [Related]

  • 39. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N, Pust S, Sandvig K.
    Biochim Biophys Acta; 2014 Sep 20; 1843(9):1987-96. PubMed ID: 24747692
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.